How Can the Public Influence the Drug Development Process?
As shown on the Drug Development and Approval Process chart, it takes 15 years, on average, for an experimental drug to travel from the laboratory to U.S. consumers. Often the longest part of the process is finding people to participate in each trial phase. With increased public awareness about clinical trials, more people may be willing to participate, and more professionals may refer people into appropriate trials. This awareness ultimately reduces the time it takes for researchers to enroll participants in trials and complete them-and speeds the movement of new drugs or treatments into standard care. Advances in Care Most of the ways we treat cancer today are based on the results of earlier clinical trials. Recent clinical trials have resulted in the following treatment benefits for people with chronic myelogenous leukemia, cervical cancer, breast cancer, and melanoma, for example. Chronic Myelogenous Leukemia-A New Treatment Option In 2001, FDA approved Gleevec, offering a new trea
Related Questions
- How has the introduction of data management systems affected the drug development process in recent years?
- How has the introduction of data management systems affected the drug development process in recent years?
- How much input and influence will the general public have on the study process?
- How much input and influence will the general public have on the study process?
- How Can the Public Influence the Drug Development Process?
- Do patients have influence on drug development?
